SCHEMBL26314530

SCHEMBL26314530

Cc1ccc2nccc(Nc3ccc(C(=O)Nc4cccc(Nc5ccncc5)c4C)cc3)c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 7/20 0.60
DNMT3A Q9Y6K1 5/20 0.60
USP2 O75604 2/20 0.57
MAPT P10636 2/20 0.57
KMT2A Q03164 2/20 0.57
DNMT3L Q9UJW3 3/20 0.54
HDAC3 O15379 1/20 0.48
ACHE P22303 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
MYC P01106 1/20 0.48
MAP2K3 P46734 1/20 0.48
EHMT2 Q96KQ7 1/20 0.48
EHMT1 Q9H9B1 1/20 0.48
DNMT3B Q9UBC3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26314595 0.90 DNMT1 (0.58) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL24003835 0.90 DNMT1 (0.58) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL30180382 0.89 DNMT1 (0.72) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL23261798 0.89 DNMT1 (0.72) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL23999647 0.89 DNMT1 (0.72) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL24003982 0.88 DNMT1 (0.66) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL24006111 0.88 DNMT1 (0.66) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL24003752 0.88 DNMT1 (0.55) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL26314544 0.86 USP2 (0.60) DNMT1DNMT3AUSP2MAPTKMT2A
SCHEMBL26314555 0.85 DNMT1 (0.64) DNMT1DNMT3AUSP2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DNMT1 4758/4885DNMT3A 4679/4885USP2 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.